Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (61-70 of 211) with videos related to

Pageof 22
Sort By:
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|June 29, 2001
Schwannoma of the tongue: report of 2 casesR Pfeifle, D A Baur, A Paulino, et al.
Journal of the National Cancer Institute|September 11, 2008
Progress in the curative treatment of childhood hematologic malignanciesAlan S Wayne, Gregory H Reaman, Lee J Helman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
Targeting cancer metabolismBeverly A Teicher, W Marston Linehan, Lee J Helman
Annals of Internal Medicine|August 1, 1984
Thrombocytopenia and extragonadal germ-cell neoplasmL J Helman, R F Ozols, D L Longo
Cancer Research|March 23, 2005
Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcomaXiaolin Wan, Arnulfo Mendoza, Chand Khanna, et al.
The New England Journal of Medicine|July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsSosipatros A Boikos, Lee J Helman, Constantine A Stratakis, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|June 1, 1982
Nasal septal abscess of dental originM da Silva, J Helman, I Eliachar, et al.
Experimental Cell Research|February 1, 1993
Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell lineG D Crouch, T Kalebic, M Tsokos, et al.
Sarcoma|January 1, 1997
Disruption of the MyoD/p21 Pathway in RhabdomyosarcomaM Weintraub, T Kalebic, L J Helman, et al.
Biochemical and Biophysical Research Communications|January 30, 1987
Inhibition of alpha 1-adrenergic responsiveness in intact cells by a new, irreversible receptor antagonistJ Helman, J W Kusiak, J Pitha, et al.
Pageof 22

Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|June 29, 2001
Schwannoma of the tongue: report of 2 casesR Pfeifle, D A Baur, A Paulino, et al.
Journal of the National Cancer Institute|September 11, 2008
Progress in the curative treatment of childhood hematologic malignanciesAlan S Wayne, Gregory H Reaman, Lee J Helman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
Targeting cancer metabolismBeverly A Teicher, W Marston Linehan, Lee J Helman
Annals of Internal Medicine|August 1, 1984
Thrombocytopenia and extragonadal germ-cell neoplasmL J Helman, R F Ozols, D L Longo
Cancer Research|March 23, 2005
Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcomaXiaolin Wan, Arnulfo Mendoza, Chand Khanna, et al.
The New England Journal of Medicine|July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsSosipatros A Boikos, Lee J Helman, Constantine A Stratakis, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|June 1, 1982
Nasal septal abscess of dental originM da Silva, J Helman, I Eliachar, et al.
Experimental Cell Research|February 1, 1993
Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell lineG D Crouch, T Kalebic, M Tsokos, et al.
Sarcoma|January 1, 1997
Disruption of the MyoD/p21 Pathway in RhabdomyosarcomaM Weintraub, T Kalebic, L J Helman, et al.
Biochemical and Biophysical Research Communications|January 30, 1987
Inhibition of alpha 1-adrenergic responsiveness in intact cells by a new, irreversible receptor antagonistJ Helman, J W Kusiak, J Pitha, et al.
Pageof 22